Search Results - "Decoster L"

Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery.

Authors: Quinten, C. Kenis, C. Decoster, L. et al.

Source: Quality of Life Research. Mar2019, Vol. 28 Issue 3, p663-676. 14p. 1 Diagram, 4 Charts, 1 Graph.

Subjects: Quality of life, Cancer chemotherapy, Older patients, Cancer patients, Geriatric Depression Scale, Cytoreductive surgery, Geriatric assessment

Targeted therapy for older patients with an oncogene driven non-small cell lung cancer: Recommendations from a SIOG expert group.

Authors: Decoster, L. Camidge, D.R. Fletcher, J.A. et al.

Source: Lung Cancer (01695002). Feb2025, Vol. 200, pN.PAG-N.PAG. 1p.

Adherence to geriatric assessment-based recommendations in older patients with cancer: a multicenter prospective cohort study in Belgium.

Authors: Kenis, C Decoster, L Flamaing, J et al.

Source: Annals of Oncology. Sep2018, Vol. 29 Issue 9, p1987-1994. 8p. 1 Diagram, 3 Charts.

Geriatric Assessment and Functional Decline in Older Patients with Lung Cancer.

Authors: Decoster, L. Kenis, C. Schallier, D. et al.

Source: Lung (0341-2040). Oct2017, Vol. 195 Issue 5, p619-626. 8p.

201P Afatinib for EGFR, HER2 or HER3 mutated solid tumors: A phase II Belgian precision study.

Authors: Decoster, L. Aftimos, P.G. Rottey, S. et al.

Source: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS262-S262. 1p.

Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations†

Authors: Decoster, L. Van Puyvelde, K. Mohile, S. et al.

Source: Annals of Oncology. Feb2015, Vol. 26 Issue 2, p288-300. 13p. 4 Charts.

Vaccination therapy for non-small-cell lung cancer: review of agents in phase III development.

Authors: Decoster, L. Wauters, I. Vansteenkiste, J. F.

Source: Annals of Oncology. Jun2012, Vol. 23 Issue 6, p1387-1393. 7p.

Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (¹⁸FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC)

Authors: Decoster, L. Schallier, D. Everaert, H. et al.

Source: Lung Cancer (01695002). Oct2008, Vol. 62 Issue 1, p55-61. 7p.

Knee valgus in self-initiated vertical jump landings : developmental and gender comparisons.

Authors: Russell, P. Swartz, E. Decoster, L. et al.

Source: 01/01/2006.

1096P Identifying predictive biomarkers for long term response on immunotherapy in non-small cell lung cancer (NSCLC).

Authors: Decoster, L. Nazari, S. De Ridder, K. et al.

Source: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS1052-S1052. 1p.

Impact of comprehensive geriatric assessment on treatment decision and follow-up in older breast cancer patients.

Authors: Kenis, C. Decoster, L. Bode, H. et al.

Source: Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p1963-1964. 2p.

1265MO Cause and place of death in older patients with cancer: Results from a large cohort study using linked clinical and population-based data.

Authors: Depoorter, V. Vanschoenbeek, K. Decoster, L. et al.

Source: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS1126-S1126. 1p.

385TiP - RIBOB: A study on the efficacy and safety of ribociclib in combination with letrozole in older women (≥70 years) with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior systemic therapy for advanced disease

Authors: Kenis, C. Ponde, N.F. Decoster, L. et al.

Source: Annals of Oncology. 2019 Supplement 6, Vol. 30, pv140-v140. 1p.

1860P Objective and subjective neurocognitive functioning (NCF) in advanced cancer survivors treated with immune checkpoint blockade (ICB).

Authors: Vanlaer, N. Dirven, I. Vounckx, M. et al.

Source: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS1004-S1004. 1p.

4250 POSTER The Role of a 3 Month Intervention Program on the Professional Reintegration of Cancer Survivors: a Pilot Study

Authors: Hanssens, S. Fontaine, C. Decoster, L. et al.

Source: European Journal of Cancer. Sep2011 Supplement 1, Vol. 47, pS322-S322. 1p.

Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study.

Authors: Kenis, C. Bron, D. Libert, Y. et al.

Source: Annals of Oncology. May2013, Vol. 24 Issue 5, p1306-1312. 7p.

Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu

Authors: De Grève, J. Teugels, E. Geers, C. et al.

Source: Lung Cancer (01695002). Apr2012, Vol. 76 Issue 1, p123-127. 5p.

1420TiP A phase I/II trial of radium-223 (Ra-223) in combination with pembrolizumab in patients (pts) with stage IV non-small cell lung cancer (NSCLC).

Authors: Reck, M. Mileham, K.F. Clump, D.A. et al.

Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS897-S898. 2p.

1363P Real-world treatment patterns of patients with locally advanced/metastatic EGFRm NSCLC in Belgium (REVEAL).

Authors: Cuppens, K. Lodewyckx, L. Demedts, I. et al.

Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS871-S872. 2p.

1037P Tumour mutational burden and HLA diversity by TruSight oncology 500 (TSO500) next generation sequencing panel and clinical outcome in non-small cell lung cancer.

Authors: Cuppens, K. Froyen, G. Cruys, B. et al.

Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS713-S714. 2p.